0.69 (3.09%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Strong
Mqv Small
Neutral
Value
Consensus
Price
Weak
Earnings
Weak
Earnings
Strong
Dividends
Very Weak
Capital Efficiency
Strong
Balance Sheet
Neutral
Website
Pacira Biosciences, Inc.
Telephone
1.813.553.6680
Address
Suite 890, 5401 West Kennedy Boulevard, Tampa, FL 33609
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 18.8 - 27.64
Trade Value (12mth)
US$4,185,432.00
1 week
-1.46%
1 month
-9.46%
YTD
-8.79%
1 year
-14.65%
All time high
121.95
EPS 3 yr Growth
-54.80%
EBITDA Margin
16.40%
Operating Cashflow
$152m
Free Cash Flow Return
13.20%
ROIC
0.60%
Interest Coverage
6.80
Quick Ratio
3.30
Shares Outstanding (Fully Diluted)
41m
HALO Sector
Healthcare
Next Company Report Date
04-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 01 May 26 | |
| 01 May 26 | |
| 01 May 26 | |
| 01 May 26 | |
| 27 February 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | 0.91 | -2.15 | 0.16 | | | | ||
EPS (Fully Diluted) | $ | | | | | 0.81 | -2.15 | 0.16 | | | | ||
Growth | % | | | | | 159.7 | -337.2 | 107.3 | | | | ||
PE | X | | | | | 41.8 | N/A | 165.7 | | | | ||
EV/EBITDA | X | | | | | 12.3 | 5.5 | 10.9 | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
